RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Activity

96 hedge funds and large institutions have $103M invested in Cartesian Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+4
Holders Change %
+4.35%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
27
Reduced
26
Closed
16
Calls
$603K
Puts
$257K
Net Calls
+$346K
Net Calls Change
+$171K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$7.95M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$3.03M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.18M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$1.37M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.1M

Top Sellers

1
MP
1
Mangrove Partners
Connecticut
$8.63M
2
AQR Capital Management
2
AQR Capital Management
Connecticut
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$150K
4
KPF
4
K2 Principal Fund
Ontario, Canada
$0
5
ECM
5
Endurant Capital Management
California
$6.46M
Name Holding Trade Value Shares
Change 		Shares
Change %
BFM
101
Boothbay Fund Management
New York
– -$35K -893 Closed
Balyasny Asset Management
102
Balyasny Asset Management
Illinois
– -$31K -788 Closed
YIH
103
Y-Intercept (HK)
Hong Kong
– -$18K -451 Closed
SG Americas Securities
104
SG Americas Securities
New York
– -$15K -385 Closed
PCM
105
Pinz Capital Management
New York
– -$14K -353 Closed
CAPTRUST Financial Advisors
106
CAPTRUST Financial Advisors
North Carolina
– -$2K -50 Closed
New York State Common Retirement Fund
107
New York State Common Retirement Fund
New York
– -$1K -30 Closed
1 2 3 4
5